Moderna's CMV vaccine shows promise in Long-Term Follow-Up study
NCT ID NCT04975893
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is a long-term follow-up of a phase 2 trial testing Moderna's mRNA-1647 vaccine against cytomegalovirus (CMV). It involves 135 adults who previously received the vaccine or a placebo. Researchers are checking how long the immune response lasts and whether a booster dose is safe and effective. The goal is to eventually prevent CMV infection, which can be dangerous for pregnant women and people with weak immune systems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mRNA-1647 vaccine
- What this could lead to
- If successful, this could support the development of a vaccine to prevent cytomegalovirus (CMV) infection, which can cause serious complications in newborns and people with weakened immune systems.
- What could go wrong
- This is a small, early-phase extension study focused on long-term immune persistence and safety, not on proving the vaccine prevents infection. The results may not confirm effectiveness, and side effects are still being evaluated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alliance for Multispeciality Research, LLC
Lexington, Kentucky, 40509, United States
-
Crossroads Clinical Research (Victoria)
Victoria, Texas, 77901, United States
-
J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah, 84109, United States
-
J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah, 84121, United States
-
Johnson County Clin-Trials, Inc.
Lenexa, Kansas, 66219, United States
-
Optimal Research, LLC
Peoria, Illinois, 61610, United States
-
Tekton Research Inc
Austin, Texas, 78745, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can cord blood t cells be trained to stop viral infections after transplant?
- Can a new IV antiviral tame two stubborn viruses?
- A new drug combo may shield kidney transplant patients from a common viral threat
- Blood test could tailor CMV prevention after stem cell transplants
- Can 'Supercharged' donor cells beat viruses that drugs Can't?
- Banked immune cells show promise against Life-Threatening viruses in transplant patients